Literature DB >> 11222683

Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes.

C Speth1, G Stöckl, I Mohsenipour, R Würzner, H Stoiber, C Lass-Flörl, M P Dierich.   

Abstract

Since the brain is separated from the blood immune system by a tight barrier, the brain-resident complement system may represent a central player in the immune defense of this compartment against human immunodeficiency virus (HIV). Chronic complement activation, however, may participate in HIV-associated neurodegeneration. Since the level of complement factors in the cerebrospinal fluid is known to be elevated in AIDS-associated neurological disorders, we evaluated the effect of HIV type 1 (HIV-1) on the complement synthesis of brain astrocytes. Incubation of different astrocytic cell lines and primary astrocytes with HIV-1 induced a marked upregulation of the expression of the complement factors C2 and C3. The synthesis of other secreted or membrane-bound complement proteins was not found to be altered. The enhancement of C3 production was measured both on the mRNA level and as secreted protein in the culture supernatants. HIV-1 laboratory strains as well as primary isolates were capable of inducing C3 production with varied effectiveness. The usage of viral coreceptors by HIV-1 was proved to be a prerequisite for the upregulation of C3 synthesis, which was modulated by the simultaneous addition of cytokines. The C3 protein which is secreted after incubation of the cells with HIV was shown to be biologically active as it can participate in the complement cascade.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222683      PMCID: PMC115884          DOI: 10.1128/JVI.75.6.2604-2516.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis.

Authors:  R Brack-Werner
Journal:  AIDS       Date:  1999-01-14       Impact factor: 4.177

Review 2.  Complement components of the innate immune system in health and disease in the CNS.

Authors:  P Gasque; Y D Dean; E P McGreal; J VanBeek; B P Morgan
Journal:  Immunopharmacology       Date:  2000-08

3.  Complement activation in amyloid plaques in Alzheimer's dementia.

Authors:  P Eikelenboom; C E Hack; J M Rozemuller; F C Stam
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

4.  HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones.

Authors:  C Speth; B Joebstl; M Barcova; M P Dierich
Journal:  AIDS       Date:  2000-04-14       Impact factor: 4.177

5.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

6.  Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.

Authors:  L Soane; H Rus; F Niculescu; M L Shin
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

7.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Distinct biological and serological properties of human immunodeficiency viruses from the brain.

Authors:  C Cheng-Mayer; J A Levy
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

9.  Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.

Authors:  C F Ebenbichler; N M Thielens; R Vornhagen; P Marschang; G J Arlaud; M P Dierich
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  24 in total

1.  Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.

Authors:  A H Shin; H J Kim; S A Thayer
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

3.  Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons.

Authors:  Cornelia Speth; Thomas Schabetsberger; Iradji Mohsenipour; Gabriele Stöckl; Reinhard Würzner; Heribert Stoiber; Cornelia Lass-Flörl; Manfred P Dierich
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS.

Authors:  Kumud K Singh; Satyanarayana Nathamu; Anthony Adame; Tara U Alire; Wilmar Dumaop; Ben Gouaux; David J Moore; Eliezer Masliah
Journal:  Neurobehav HIV Med       Date:  2011-05-01

5.  Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis.

Authors:  Edward A Acheampong; Cassandra Roschel; Muhammad Mukhtar; Alagarsamy Srinivasan; Mohammad Rafi; Roger J Pomerantz; Zahida Parveen
Journal:  Virol J       Date:  2009-10-30       Impact factor: 4.099

6.  Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.

Authors:  Nicholas J Hargus; Stanley A Thayer
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

7.  Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.

Authors:  Diane L Sewell; Brendon Nacewicz; Frances Liu; Sinarack Macvilay; Anna Erdei; John D Lambris; Matyas Sandor; Zsuzsa Fabry
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

8.  Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.

Authors:  Hee Jung Kim; Kirill A Martemyanov; Stanley A Thayer
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

9.  Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures.

Authors:  Angela H Shin; Stanley A Thayer
Journal:  Mol Cell Neurosci       Date:  2012-12-23       Impact factor: 4.314

Review 10.  Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease.

Authors:  Matthew J Bellizzi; Shao-Ming Lu; Harris A Gelbard
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.